Replies to post #111919 on Biotech Values

[zipjet]

I agree that the accounting treatment will NOT change cash flows nor the value of MNTA.

But it seems silly to me to make an accounting entry that recognizes the value of an asset (deferred tax asset) that may then need to be written off (reversing the entry) any day.

ij